Paul Miller

science

[Paul Miller @PMillerLab]

Exciting postdoc opportunity in Cambridge Protein Screening Facility for binder platform development! Part of great team! Run by @PMillerLab @LauraItzhaki @HyvonenGroup @HowarthSci @hollfelderlab @DrCathyWilson and Sormanni labs! https://t.co/vUg0HNOr6M @UnivCamPharm @CamBiochem

[Paul Miller @PMillerLab]

@RahmanLab Super nice!

[Paul Miller @PMillerLab]

@saad_hannan @uclbiosciences @blizard_inst Fantastic effort!

[Paul Miller @PMillerLab]

Congrats to @PMillerLab and @UnivCamPharm protégé, Mr (now Dr!) Ollie King on successful defence of his PhD thesis! Huge thanks to Dr Janet Kumita @jrkumita and Dr Greta Hultqvist for putting Ollie through his paces!

[Paul Miller @PMillerLab]

@CMS_CDG_Oxford @Anna_Liiiiiiii @inwardopen It was a pleasure. Great to see you again and catch up!

[Paul Miller @PMillerLab]

@HowarthSci @UnivCamPharm @BBSRC @Ox_DTP Congrats! Power to the protein, as they say!

[Paul Miller @PMillerLab]

@RyanHibbs10 Congratulations, Ryan. Fantastic achievement by all involved! I look forward to reading it!

[Paul Miller @PMillerLab]

Great postdoc opportunities designing antibodies/ligases/proteases for Modular Activator and Silencer Therapeutics (MAST). Mentor support @PMillerLab @LauraItzhaki @HowarthSci @hollfelderlab @DrCathyWilson and Sormanni labs! https://t.co/n7Nc2AzbDd @UnivCamPharm

[Paul Miller @PMillerLab]

@GpcrL Super fantastic!

[Paul Miller @PMillerLab]

New £100m fund will unlock the potential of engineering biology https://t.co/hj7iMZcbfR

[Paul Miller @PMillerLab]

@PMillerLab @UnivCamPharm excited to soon work on building protein modular arrays for MAST: Modular Activator and Silencer Therapeutics with @LauraItzhaki @HowarthSci @holfelderlab @DrCathyWilson and Sormanni labs, supported by generous UKRI Engineering Biology funding @BBSRC!

[Paul Miller @PMillerLab]

Two magnificent opportunities here in Cambridge pharmacology!

[Ewan St. John Smith @psalmotoxin]

Two exciting Assistant/Associate Professor opportunities @UnivCamPharm:

Post 1 - Ageing/Neurodegeneration https://t.co/9sUum7bpKr

Post 2 - Structural & Molecular Pharmacology https://t.co/CfvUlnDdja

It’s a great place to work, please reach out if you’re interested!

[Paul Miller @PMillerLab]

Great opportunity here!

[Dept. of Pharmacology, Univ. Cambridge @UnivCamPharm]

Interested in cutting edge sigalling research? The @GpcrL Group is recruting for a #Research Assistant/Associate to support their research into GPCR signalling 🔬

For more information please click here 👉https://t.co/vqoGrnuy7V

[Paul Miller @PMillerLab]

For the isoxazoles we observed interesting pocket displacements between negative vs positive modulators, the first such structure-activity relationship observed for a GABA-A receptor, and hope this study can empower future drug-design efforts against this valuable target.

[Paul Miller @PMillerLab]

The Miller lab is super proud to have published its work on GABA-A receptor α5 selective modulators, in Nature Structural and Molecular Biology! https://t.co/6H3PCqlXDC. @NatureSMB @vikrambabu @t_malinauskas @RaduAricescu @UnivCamPharm @BiocEMcam

[Paul Miller @PMillerLab]

We used radioligand binding, ePhys and cryo-EM studies to give detailed insight into b-carboline, benzo, and isoxazole selectivity. Special thanks to Maria-Clemencia Hernandez & Giuseppe Cecere at Roche for support and some wonderful compounds to study!

[Paul Miller @PMillerLab]

The Miller lab @UnivCamPharm is looking for an enthusiastic postdoc to study antibody modulation of ion channels!

A previous relevant publication from our group is https://t.co/XTBPsCJrWh

Job details 👉 https://t.co/cV4aojH2dK

DEADLINE 30th NOVEMBER

[Paul Miller @PMillerLab]

@RahmanLab I bet they loved it!

[Paul Miller @PMillerLab]

@psalmotoxin This one made me laugh!